Historique
Bulletin de Périodique
Addiction , Vol.119, n°8 - August 2024
Paru le :
01/08/2024
Article en page(s) :
1331-1497
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future [Editorial]. Griffiths P.N., Seyler T., De Morais J.M., Mounteney J.E., Sedefov R.S., p. 1334-1336.
- Opportunistic smoking cessation interventions for people accessing financial support settings: A scoping review. Doody P., Parkhouse T., Gao M., Haasova S., Livingstone-Banks J., Cheeseman H., et al., p. 1337-1351.
- Effect of 3 months and 12?months of financial incentives on 12-month postpartum smoking cessation maintenance: A randomized controlled trial. Ussher M., Best C., Lewis S., McKell J., Coleman T., Cooper S., et al., p. 1352-1363.
- Commentary on Ussher et al.: Duration and magnitude of postpartum financial incentives for the maintenance of cigarette smoking abstinence. Kock L.S., Higgins S.T., Heil S.H., p. 1364-1365.
- Behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India and Pakistan: A pilot randomized controlled trial. Siddiqui F., Kanaan M., Croucher R., Bauld L., Fieroze F., Kumar P., et al., p. 1366-1377.
- Evaluating the impact of minimum unit pricing (MUP) on alcohol sales after 3 years of implementation in Scotland: A controlled interrupted time-series study. Giles L., Mackay D., Richardson E., Lewsey J., Robinson M., Beeston C., p. 1378-1386.
- Alcohol consumption and accelerated biological ageing in middle-aged and older people: A longitudinal study from two cohorts. Chen H., Yin J., Xiang Y., Zhang N., Huang Z., Zhang Y., et al., p. 1387-1399.
- Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019-21. Takemoto E., Bolton A., Goetz C.T., p. 1400-1409.
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study. Markoulidakis A., Hickman M., McAuley A., Barnsdale L.R., Welton N.J., Glancy M., et al., p. 1410-1420.
- Prolonged diacetylmorphine take-home during the COVID-19 pandemic - Results of a retrospective cohort study. Brezan F., Meyer M., Vogel M., Heimer J., Falcato L., Montagna J., et al., p. 1421-1429.
- Gambling participation and risk after COVID-19: Analysis of a population representative longitudinal panel of Australians. Suomi A., Kim J., Hahn M.H., Biddle N., p. 1430-1439.
- Substance use treatment completion and criminal justice system contact in Chile: A retrospective, linked data cohort study. Mateo Pinones M., González-Santa Cruz A., Castillo-Carniglia A., Bond C., Payne J., McGee T.R., p. 1440-1452.
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada. Guerra-Alejos B.C., Yan Y., Kurz M., Mudalige N., Min J.E., Homayra F., et al., p. 1453-1459.
- Harm from the drinking of people you know: A range of effects from different relationships. Laslett A.M., Anderson-Luxford D., Willoughby B., Room R., Doran C., Egerton-Warburton D., et al., p. 1460-1467.
- Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial. Li W.H.C., Lam D.C.L., Sin K.M., Wong E.L.Y., Wong C.K.H., Loong H.H.F., et al., p. 1468-1477.
- Harmful compared to what? The problem of gaming and ambiguous causal questions. Magnusson K., Johansson F., Przybylski A.K., p. 1478-1486.
- The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco. Rodda L.N., p. 1487-1490.
- Vaping in pregnancy: Caution required! Bush A., Coutts J., Langley R., p. 1491-1492.
- Pregnant smokers can be encouraged to switch to vaping. Pesola F., Smith K.M., Phillips-Waller A., Przulj D., Walton R., McRobbie H., et al., p. 1493-1494.
- Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future [Editorial]. Griffiths P.N., Seyler T., De Morais J.M., Mounteney J.E., Sedefov R.S., p. 1334-1336.
- Opportunistic smoking cessation interventions for people accessing financial support settings: A scoping review. Doody P., Parkhouse T., Gao M., Haasova S., Livingstone-Banks J., Cheeseman H., et al., p. 1337-1351.
- Effect of 3 months and 12?months of financial incentives on 12-month postpartum smoking cessation maintenance: A randomized controlled trial. Ussher M., Best C., Lewis S., McKell J., Coleman T., Cooper S., et al., p. 1352-1363.
- Commentary on Ussher et al.: Duration and magnitude of postpartum financial incentives for the maintenance of cigarette smoking abstinence. Kock L.S., Higgins S.T., Heil S.H., p. 1364-1365.
- Behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India and Pakistan: A pilot randomized controlled trial. Siddiqui F., Kanaan M., Croucher R., Bauld L., Fieroze F., Kumar P., et al., p. 1366-1377.
- Evaluating the impact of minimum unit pricing (MUP) on alcohol sales after 3 years of implementation in Scotland: A controlled interrupted time-series study. Giles L., Mackay D., Richardson E., Lewsey J., Robinson M., Beeston C., p. 1378-1386.
- Alcohol consumption and accelerated biological ageing in middle-aged and older people: A longitudinal study from two cohorts. Chen H., Yin J., Xiang Y., Zhang N., Huang Z., Zhang Y., et al., p. 1387-1399.
- Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019-21. Takemoto E., Bolton A., Goetz C.T., p. 1400-1409.
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study. Markoulidakis A., Hickman M., McAuley A., Barnsdale L.R., Welton N.J., Glancy M., et al., p. 1410-1420.
- Prolonged diacetylmorphine take-home during the COVID-19 pandemic - Results of a retrospective cohort study. Brezan F., Meyer M., Vogel M., Heimer J., Falcato L., Montagna J., et al., p. 1421-1429.
- Gambling participation and risk after COVID-19: Analysis of a population representative longitudinal panel of Australians. Suomi A., Kim J., Hahn M.H., Biddle N., p. 1430-1439.
- Substance use treatment completion and criminal justice system contact in Chile: A retrospective, linked data cohort study. Mateo Pinones M., González-Santa Cruz A., Castillo-Carniglia A., Bond C., Payne J., McGee T.R., p. 1440-1452.
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada. Guerra-Alejos B.C., Yan Y., Kurz M., Mudalige N., Min J.E., Homayra F., et al., p. 1453-1459.
- Harm from the drinking of people you know: A range of effects from different relationships. Laslett A.M., Anderson-Luxford D., Willoughby B., Room R., Doran C., Egerton-Warburton D., et al., p. 1460-1467.
- Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial. Li W.H.C., Lam D.C.L., Sin K.M., Wong E.L.Y., Wong C.K.H., Loong H.H.F., et al., p. 1468-1477.
- Harmful compared to what? The problem of gaming and ambiguous causal questions. Magnusson K., Johansson F., Przybylski A.K., p. 1478-1486.
- The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco. Rodda L.N., p. 1487-1490.
- Vaping in pregnancy: Caution required! Bush A., Coutts J., Langley R., p. 1491-1492.
- Pregnant smokers can be encouraged to switch to vaping. Pesola F., Smith K.M., Phillips-Waller A., Przulj D., Walton R., McRobbie H., et al., p. 1493-1494.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
![Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_87210.webp)
P. N. GRIFFITHS ;
T. SEYLER ;
J. M. DE MORAIS ;
J. E. MOUNTENEY ;
R. S. SEDEFOV
|
2024
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
Heroin has been the opioid most associate with harm in Europe; however, this may be changing. Recently there are signals that synthetic opioids could play a more important role in the future creating a need to be better prepared to respond to an[...]
Nouveauté
A. MARKOULIDAKIS ;
M. HICKMAN ;
A. McAULEY ;
L. R. BARNSDALE ;
N. J. WELTON ;
M. GLANCY ;
T. SHIVAJI ;
C. COLLINS ;
J. LANG ;
F. DE WIT ;
G. HUNT ;
L. WILKINSON ;
R. FRASER ;
A. YEUNG ;
K. HORSBURGH ;
S. PRIYADARSHI ;
S. J. HUTCHINSON ;
H. E. JONES
|
2024
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
BACKGROUND AND AIMS: Drug-related deaths in Scotland more than doubled between 2011 and 2020. To inform policymakers and understand drivers of this increase, we estimated the number of people with opioid dependence aged 15-64 from 2014/15 to 201[...]
Nouveauté
A. M. LASLETT ;
D. ANDERSON-LUXFORD ;
B. WILLOUGHBY ;
R. ROOM ;
C. DORAN ;
D. EGERTON-WARBURTON ;
R. JENKINSON ;
K. SMIT ;
H. JIANG
|
2024
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
Dans Addiction (Vol.119, n°8, August 2024) Article : Périodique
AIMS: To describe the range of effects experienced due to the drinking of people respondents know and analyze risk and protective factors for harm from the drinking of partners and household members, other relatives and friends and co-workers.
[...]